Global OTC Pet Medication Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/global-otc-pet-medication-market-size-status-n-forecast-2020-2026_en.gif)
OTC Pet Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global OTC Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
The key players covered in this study
- Bayer Companion Animal
- Boehringer Ingelheim Animal Health
- Ceva Sante Animale
- Merck Inc.
- Zoetis Inc.
- Elanco
- Virbac SA
- Vetoquinol SA
- Frontline
- Zymox
- ChloraSeb
- Sulfox
- Adequan
- Dechra Pharmaceuticals PLC
- Nutramax Laboratories, Inc.
- Fleas & Ticks Removal
- Pain Relief & Arthritis
- Dewormers
- Others
- Dogs & Cats
- Birds
- Fish & Reptiles
- Others
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OTC Pet Medication Revenue
1.4 Market by Type
1.4.1 Global OTC Pet Medication Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fleas & Ticks Removal
1.4.3 Pain Relief & Arthritis
1.4.4 Dewormers
1.4.5 Others
1.5 Market by Application
1.5.1 Global OTC Pet Medication Market Share by Application: 2020 VS 2026
1.5.2 Dogs & Cats
1.5.3 Birds
1.5.4 Fish & Reptiles
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global OTC Pet Medication Market Perspective (2015-2026)
2.2 Global OTC Pet Medication Growth Trends by Regions
2.2.1 OTC Pet Medication Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 OTC Pet Medication Historic Market Share by Regions (2015-2020)
2.2.3 OTC Pet Medication Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 OTC Pet Medication Market Growth Strategy
2.3.6 Primary Interviews with Key OTC Pet Medication Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top OTC Pet Medication Players by Market Size
3.1.1 Global Top OTC Pet Medication Players by Revenue (2015-2020)
3.1.2 Global OTC Pet Medication Revenue Market Share by Players (2015-2020)
3.1.3 Global OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global OTC Pet Medication Market Concentration Ratio
3.2.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by OTC Pet Medication Revenue in 2019
3.3 OTC Pet Medication Key Players Head office and Area Served
3.4 Key Players OTC Pet Medication Product Solution and Service
3.5 Date of Enter into OTC Pet Medication Market
3.6 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE (2015-2026)
4.1 Global OTC Pet Medication Historic Market Size by Type (2015-2020)
4.2 Global OTC Pet Medication Forecasted Market Size by Type (2021-2026)
5 MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global OTC Pet Medication Market Size by Application (2015-2020)
5.2 Global OTC Pet Medication Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Pet Medication Market Size (2015-2020)
6.2 OTC Pet Medication Key Players in North America (2019-2020)
6.3 North America OTC Pet Medication Market Size by Type (2015-2020)
6.4 North America OTC Pet Medication Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe OTC Pet Medication Market Size (2015-2020)
7.2 OTC Pet Medication Key Players in Europe (2019-2020)
7.3 Europe OTC Pet Medication Market Size by Type (2015-2020)
7.4 Europe OTC Pet Medication Market Size by Application (2015-2020)
8 CHINA
8.1 China OTC Pet Medication Market Size (2015-2020)
8.2 OTC Pet Medication Key Players in China (2019-2020)
8.3 China OTC Pet Medication Market Size by Type (2015-2020)
8.4 China OTC Pet Medication Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan OTC Pet Medication Market Size (2015-2020)
9.2 OTC Pet Medication Key Players in Japan (2019-2020)
9.3 Japan OTC Pet Medication Market Size by Type (2015-2020)
9.4 Japan OTC Pet Medication Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia OTC Pet Medication Market Size (2015-2020)
10.2 OTC Pet Medication Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia OTC Pet Medication Market Size by Type (2015-2020)
10.4 Southeast Asia OTC Pet Medication Market Size by Application (2015-2020)
11 INDIA
11.1 India OTC Pet Medication Market Size (2015-2020)
11.2 OTC Pet Medication Key Players in India (2019-2020)
11.3 India OTC Pet Medication Market Size by Type (2015-2020)
11.4 India OTC Pet Medication Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America OTC Pet Medication Market Size (2015-2020)
12.2 OTC Pet Medication Key Players in Central & South America (2019-2020)
12.3 Central & South America OTC Pet Medication Market Size by Type (2015-2020)
12.4 Central & South America OTC Pet Medication Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Bayer Companion Animal
13.1.1 Bayer Companion Animal Company Details
13.1.2 Bayer Companion Animal Business Overview
13.1.3 Bayer Companion Animal OTC Pet Medication Introduction
13.1.4 Bayer Companion Animal Revenue in OTC Pet Medication Business (2015-2020))
13.1.5 Bayer Companion Animal Recent Development
13.2 Boehringer Ingelheim Animal Health
13.2.1 Boehringer Ingelheim Animal Health Company Details
13.2.2 Boehringer Ingelheim Animal Health Business Overview
13.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Introduction
13.2.4 Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2015-2020)
13.2.5 Boehringer Ingelheim Animal Health Recent Development
13.3 Ceva Sante Animale
13.3.1 Ceva Sante Animale Company Details
13.3.2 Ceva Sante Animale Business Overview
13.3.3 Ceva Sante Animale OTC Pet Medication Introduction
13.3.4 Ceva Sante Animale Revenue in OTC Pet Medication Business (2015-2020)
13.3.5 Ceva Sante Animale Recent Development
13.4 Merck Inc.
13.4.1 Merck Inc. Company Details
13.4.2 Merck Inc. Business Overview
13.4.3 Merck Inc. OTC Pet Medication Introduction
13.4.4 Merck Inc. Revenue in OTC Pet Medication Business (2015-2020)
13.4.5 Merck Inc. Recent Development
13.5 Zoetis Inc.
13.5.1 Zoetis Inc. Company Details
13.5.2 Zoetis Inc. Business Overview
13.5.3 Zoetis Inc. OTC Pet Medication Introduction
13.5.4 Zoetis Inc. Revenue in OTC Pet Medication Business (2015-2020)
13.5.5 Zoetis Inc. Recent Development
13.6 Elanco
13.6.1 Elanco Company Details
13.6.2 Elanco Business Overview
13.6.3 Elanco OTC Pet Medication Introduction
13.6.4 Elanco Revenue in OTC Pet Medication Business (2015-2020)
13.6.5 Elanco Recent Development
13.7 Virbac SA
13.7.1 Virbac SA Company Details
13.7.2 Virbac SA Business Overview
13.7.3 Virbac SA OTC Pet Medication Introduction
13.7.4 Virbac SA Revenue in OTC Pet Medication Business (2015-2020)
13.7.5 Virbac SA Recent Development
13.8 Vetoquinol SA
13.8.1 Vetoquinol SA Company Details
13.8.2 Vetoquinol SA Business Overview
13.8.3 Vetoquinol SA OTC Pet Medication Introduction
13.8.4 Vetoquinol SA Revenue in OTC Pet Medication Business (2015-2020)
13.8.5 Vetoquinol SA Recent Development
13.9 Frontline
13.9.1 Frontline Company Details
13.9.2 Frontline Business Overview
13.9.3 Frontline OTC Pet Medication Introduction
13.9.4 Frontline Revenue in OTC Pet Medication Business (2015-2020)
13.9.5 Frontline Recent Development
13.10 Zymox
13.10.1 Zymox Company Details
13.10.2 Zymox Business Overview
13.10.3 Zymox OTC Pet Medication Introduction
13.10.4 Zymox Revenue in OTC Pet Medication Business (2015-2020)
13.10.5 Zymox Recent Development
13.11 ChloraSeb
10.11.1 ChloraSeb Company Details
10.11.2 ChloraSeb Business Overview
10.11.3 ChloraSeb OTC Pet Medication Introduction
10.11.4 ChloraSeb Revenue in OTC Pet Medication Business (2015-2020)
10.11.5 ChloraSeb Recent Development
13.12 Sulfox
10.12.1 Sulfox Company Details
10.12.2 Sulfox Business Overview
10.12.3 Sulfox OTC Pet Medication Introduction
10.12.4 Sulfox Revenue in OTC Pet Medication Business (2015-2020)
10.12.5 Sulfox Recent Development
13.13 Adequan
10.13.1 Adequan Company Details
10.13.2 Adequan Business Overview
10.13.3 Adequan OTC Pet Medication Introduction
10.13.4 Adequan Revenue in OTC Pet Medication Business (2015-2020)
10.13.5 Adequan Recent Development
13.14 Dechra Pharmaceuticals PLC
10.14.1 Dechra Pharmaceuticals PLC Company Details
10.14.2 Dechra Pharmaceuticals PLC Business Overview
10.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Introduction
10.14.4 Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2015-2020)
10.14.5 Dechra Pharmaceuticals PLC Recent Development
13.15 Nutramax Laboratories, Inc.
10.15.1 Nutramax Laboratories, Inc. Company Details
10.15.2 Nutramax Laboratories, Inc. Business Overview
10.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Introduction
10.15.4 Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2015-2020)
10.15.5 Nutramax Laboratories, Inc. Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OTC Pet Medication Revenue
1.4 Market by Type
1.4.1 Global OTC Pet Medication Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fleas & Ticks Removal
1.4.3 Pain Relief & Arthritis
1.4.4 Dewormers
1.4.5 Others
1.5 Market by Application
1.5.1 Global OTC Pet Medication Market Share by Application: 2020 VS 2026
1.5.2 Dogs & Cats
1.5.3 Birds
1.5.4 Fish & Reptiles
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global OTC Pet Medication Market Perspective (2015-2026)
2.2 Global OTC Pet Medication Growth Trends by Regions
2.2.1 OTC Pet Medication Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 OTC Pet Medication Historic Market Share by Regions (2015-2020)
2.2.3 OTC Pet Medication Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 OTC Pet Medication Market Growth Strategy
2.3.6 Primary Interviews with Key OTC Pet Medication Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top OTC Pet Medication Players by Market Size
3.1.1 Global Top OTC Pet Medication Players by Revenue (2015-2020)
3.1.2 Global OTC Pet Medication Revenue Market Share by Players (2015-2020)
3.1.3 Global OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global OTC Pet Medication Market Concentration Ratio
3.2.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by OTC Pet Medication Revenue in 2019
3.3 OTC Pet Medication Key Players Head office and Area Served
3.4 Key Players OTC Pet Medication Product Solution and Service
3.5 Date of Enter into OTC Pet Medication Market
3.6 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE (2015-2026)
4.1 Global OTC Pet Medication Historic Market Size by Type (2015-2020)
4.2 Global OTC Pet Medication Forecasted Market Size by Type (2021-2026)
5 MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global OTC Pet Medication Market Size by Application (2015-2020)
5.2 Global OTC Pet Medication Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Pet Medication Market Size (2015-2020)
6.2 OTC Pet Medication Key Players in North America (2019-2020)
6.3 North America OTC Pet Medication Market Size by Type (2015-2020)
6.4 North America OTC Pet Medication Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe OTC Pet Medication Market Size (2015-2020)
7.2 OTC Pet Medication Key Players in Europe (2019-2020)
7.3 Europe OTC Pet Medication Market Size by Type (2015-2020)
7.4 Europe OTC Pet Medication Market Size by Application (2015-2020)
8 CHINA
8.1 China OTC Pet Medication Market Size (2015-2020)
8.2 OTC Pet Medication Key Players in China (2019-2020)
8.3 China OTC Pet Medication Market Size by Type (2015-2020)
8.4 China OTC Pet Medication Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan OTC Pet Medication Market Size (2015-2020)
9.2 OTC Pet Medication Key Players in Japan (2019-2020)
9.3 Japan OTC Pet Medication Market Size by Type (2015-2020)
9.4 Japan OTC Pet Medication Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia OTC Pet Medication Market Size (2015-2020)
10.2 OTC Pet Medication Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia OTC Pet Medication Market Size by Type (2015-2020)
10.4 Southeast Asia OTC Pet Medication Market Size by Application (2015-2020)
11 INDIA
11.1 India OTC Pet Medication Market Size (2015-2020)
11.2 OTC Pet Medication Key Players in India (2019-2020)
11.3 India OTC Pet Medication Market Size by Type (2015-2020)
11.4 India OTC Pet Medication Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America OTC Pet Medication Market Size (2015-2020)
12.2 OTC Pet Medication Key Players in Central & South America (2019-2020)
12.3 Central & South America OTC Pet Medication Market Size by Type (2015-2020)
12.4 Central & South America OTC Pet Medication Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Bayer Companion Animal
13.1.1 Bayer Companion Animal Company Details
13.1.2 Bayer Companion Animal Business Overview
13.1.3 Bayer Companion Animal OTC Pet Medication Introduction
13.1.4 Bayer Companion Animal Revenue in OTC Pet Medication Business (2015-2020))
13.1.5 Bayer Companion Animal Recent Development
13.2 Boehringer Ingelheim Animal Health
13.2.1 Boehringer Ingelheim Animal Health Company Details
13.2.2 Boehringer Ingelheim Animal Health Business Overview
13.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Introduction
13.2.4 Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2015-2020)
13.2.5 Boehringer Ingelheim Animal Health Recent Development
13.3 Ceva Sante Animale
13.3.1 Ceva Sante Animale Company Details
13.3.2 Ceva Sante Animale Business Overview
13.3.3 Ceva Sante Animale OTC Pet Medication Introduction
13.3.4 Ceva Sante Animale Revenue in OTC Pet Medication Business (2015-2020)
13.3.5 Ceva Sante Animale Recent Development
13.4 Merck Inc.
13.4.1 Merck Inc. Company Details
13.4.2 Merck Inc. Business Overview
13.4.3 Merck Inc. OTC Pet Medication Introduction
13.4.4 Merck Inc. Revenue in OTC Pet Medication Business (2015-2020)
13.4.5 Merck Inc. Recent Development
13.5 Zoetis Inc.
13.5.1 Zoetis Inc. Company Details
13.5.2 Zoetis Inc. Business Overview
13.5.3 Zoetis Inc. OTC Pet Medication Introduction
13.5.4 Zoetis Inc. Revenue in OTC Pet Medication Business (2015-2020)
13.5.5 Zoetis Inc. Recent Development
13.6 Elanco
13.6.1 Elanco Company Details
13.6.2 Elanco Business Overview
13.6.3 Elanco OTC Pet Medication Introduction
13.6.4 Elanco Revenue in OTC Pet Medication Business (2015-2020)
13.6.5 Elanco Recent Development
13.7 Virbac SA
13.7.1 Virbac SA Company Details
13.7.2 Virbac SA Business Overview
13.7.3 Virbac SA OTC Pet Medication Introduction
13.7.4 Virbac SA Revenue in OTC Pet Medication Business (2015-2020)
13.7.5 Virbac SA Recent Development
13.8 Vetoquinol SA
13.8.1 Vetoquinol SA Company Details
13.8.2 Vetoquinol SA Business Overview
13.8.3 Vetoquinol SA OTC Pet Medication Introduction
13.8.4 Vetoquinol SA Revenue in OTC Pet Medication Business (2015-2020)
13.8.5 Vetoquinol SA Recent Development
13.9 Frontline
13.9.1 Frontline Company Details
13.9.2 Frontline Business Overview
13.9.3 Frontline OTC Pet Medication Introduction
13.9.4 Frontline Revenue in OTC Pet Medication Business (2015-2020)
13.9.5 Frontline Recent Development
13.10 Zymox
13.10.1 Zymox Company Details
13.10.2 Zymox Business Overview
13.10.3 Zymox OTC Pet Medication Introduction
13.10.4 Zymox Revenue in OTC Pet Medication Business (2015-2020)
13.10.5 Zymox Recent Development
13.11 ChloraSeb
10.11.1 ChloraSeb Company Details
10.11.2 ChloraSeb Business Overview
10.11.3 ChloraSeb OTC Pet Medication Introduction
10.11.4 ChloraSeb Revenue in OTC Pet Medication Business (2015-2020)
10.11.5 ChloraSeb Recent Development
13.12 Sulfox
10.12.1 Sulfox Company Details
10.12.2 Sulfox Business Overview
10.12.3 Sulfox OTC Pet Medication Introduction
10.12.4 Sulfox Revenue in OTC Pet Medication Business (2015-2020)
10.12.5 Sulfox Recent Development
13.13 Adequan
10.13.1 Adequan Company Details
10.13.2 Adequan Business Overview
10.13.3 Adequan OTC Pet Medication Introduction
10.13.4 Adequan Revenue in OTC Pet Medication Business (2015-2020)
10.13.5 Adequan Recent Development
13.14 Dechra Pharmaceuticals PLC
10.14.1 Dechra Pharmaceuticals PLC Company Details
10.14.2 Dechra Pharmaceuticals PLC Business Overview
10.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Introduction
10.14.4 Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2015-2020)
10.14.5 Dechra Pharmaceuticals PLC Recent Development
13.15 Nutramax Laboratories, Inc.
10.15.1 Nutramax Laboratories, Inc. Company Details
10.15.2 Nutramax Laboratories, Inc. Business Overview
10.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Introduction
10.15.4 Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2015-2020)
10.15.5 Nutramax Laboratories, Inc. Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. OTC Pet Medication Key Market Segments
Table 2. Key Players Covered: Ranking by OTC Pet Medication Revenue
Table 3. Ranking of Global Top OTC Pet Medication Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global OTC Pet Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fleas & Ticks Removal
Table 6. Key Players of Pain Relief & Arthritis
Table 7. Key Players of Dewormers
Table 8. Key Players of Others
Table 9. Global OTC Pet Medication Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global OTC Pet Medication Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global OTC Pet Medication Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global OTC Pet Medication Market Share by Regions (2015-2020)
Table 13. Global OTC Pet Medication Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global OTC Pet Medication Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. OTC Pet Medication Market Growth Strategy
Table 19. Main Points Interviewed from Key OTC Pet Medication Players
Table 20. Global OTC Pet Medication Revenue by Players (2015-2020) (Million US$)
Table 21. Global OTC Pet Medication Market Share by Players (2015-2020)
Table 22. Global Top OTC Pet Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Pet Medication as of 2019)
Table 23. Global OTC Pet Medication by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players OTC Pet Medication Product Solution and Service
Table 26. Date of Enter into OTC Pet Medication Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 29. Global OTC Pet Medication Market Size Share by Type (2015-2020)
Table 30. Global OTC Pet Medication Revenue Market Share by Type (2021-2026)
Table 31. Global OTC Pet Medication Market Size Share by Application (2015-2020)
Table 32. Global OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 33. Global OTC Pet Medication Market Size Share by Application (2021-2026)
Table 34. North America Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 35. North America Key Players OTC Pet Medication Market Share (2019-2020)
Table 36. North America OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 37. North America OTC Pet Medication Market Share by Type (2015-2020)
Table 38. North America OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 39. North America OTC Pet Medication Market Share by Application (2015-2020)
Table 40. Europe Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players OTC Pet Medication Market Share (2019-2020)
Table 42. Europe OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 43. Europe OTC Pet Medication Market Share by Type (2015-2020)
Table 44. Europe OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 45. Europe OTC Pet Medication Market Share by Application (2015-2020)
Table 46. China Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 47. China Key Players OTC Pet Medication Market Share (2019-2020)
Table 48. China OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 49. China OTC Pet Medication Market Share by Type (2015-2020)
Table 50. China OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 51. China OTC Pet Medication Market Share by Application (2015-2020)
Table 52. Japan Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players OTC Pet Medication Market Share (2019-2020)
Table 54. Japan OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 55. Japan OTC Pet Medication Market Share by Type (2015-2020)
Table 56. Japan OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 57. Japan OTC Pet Medication Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players OTC Pet Medication Market Share (2019-2020)
Table 60. Southeast Asia OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia OTC Pet Medication Market Share by Type (2015-2020)
Table 62. Southeast Asia OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia OTC Pet Medication Market Share by Application (2015-2020)
Table 64. India Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 65. India Key Players OTC Pet Medication Market Share (2019-2020)
Table 66. India OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 67. India OTC Pet Medication Market Share by Type (2015-2020)
Table 68. India OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 69. India OTC Pet Medication Market Share by Application (2015-2020)
Table 70. Central & South America Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players OTC Pet Medication Market Share (2019-2020)
Table 72. Central & South America OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America OTC Pet Medication Market Share by Type (2015-2020)
Table 74. Central & South America OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America OTC Pet Medication Market Share by Application (2015-2020)
Table 76. Bayer Companion Animal Company Details
Table 77. Bayer Companion Animal Business Overview
Table 78. Bayer Companion Animal Product
Table 79. Bayer Companion Animal Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 80. Bayer Companion Animal Recent Development
Table 81. Boehringer Ingelheim Animal Health Company Details
Table 82. Boehringer Ingelheim Animal Health Business Overview
Table 83. Boehringer Ingelheim Animal Health Product
Table 84. Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 85. Boehringer Ingelheim Animal Health Recent Development
Table 86. Ceva Sante Animale Company Details
Table 87. Ceva Sante Animale Business Overview
Table 88. Ceva Sante Animale Product
Table 89. Ceva Sante Animale Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 90. Ceva Sante Animale Recent Development
Table 91. Merck Inc. Company Details
Table 92. Merck Inc. Business Overview
Table 93. Merck Inc. Product
Table 94. Merck Inc. Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 95. Merck Inc. Recent Development
Table 96. Zoetis Inc. Company Details
Table 97. Zoetis Inc. Business Overview
Table 98. Zoetis Inc. Product
Table 99. Zoetis Inc. Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 100. Zoetis Inc. Recent Development
Table 101. Elanco Company Details
Table 102. Elanco Business Overview
Table 103. Elanco Product
Table 104. Elanco Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 105. Elanco Recent Development
Table 106. Virbac SA Company Details
Table 107. Virbac SA Business Overview
Table 108. Virbac SA Product
Table 109. Virbac SA Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 110. Virbac SA Recent Development
Table 111. Vetoquinol SA Business Overview
Table 112. Vetoquinol SA Product
Table 113. Vetoquinol SA Company Details
Table 114. Vetoquinol SA Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 115. Vetoquinol SA Recent Development
Table 116. Frontline Company Details
Table 117. Frontline Business Overview
Table 118. Frontline Product
Table 119. Frontline Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 120. Frontline Recent Development
Table 121. Zymox Company Details
Table 122. Zymox Business Overview
Table 123. Zymox Product
Table 124. Zymox Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 125. Zymox Recent Development
Table 126. ChloraSeb Company Details
Table 127. ChloraSeb Business Overview
Table 128. ChloraSeb Product
Table 129. ChloraSeb Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 130. ChloraSeb Recent Development
Table 131. Sulfox Company Details
Table 132. Sulfox Business Overview
Table 133. Sulfox Product
Table 134. Sulfox Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 135. Sulfox Recent Development
Table 136. Adequan Company Details
Table 137. Adequan Business Overview
Table 138. Adequan Product
Table 139. Adequan Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 140. Adequan Recent Development
Table 141. Dechra Pharmaceuticals PLC Company Details
Table 142. Dechra Pharmaceuticals PLC Business Overview
Table 143. Dechra Pharmaceuticals PLC Product
Table 144. Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 145. Dechra Pharmaceuticals PLC Recent Development
Table 146. Nutramax Laboratories, Inc. Company Details
Table 147. Nutramax Laboratories, Inc. Business Overview
Table 148. Nutramax Laboratories, Inc. Product
Table 149. Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 150. Nutramax Laboratories, Inc. Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 1. OTC Pet Medication Key Market Segments
Table 2. Key Players Covered: Ranking by OTC Pet Medication Revenue
Table 3. Ranking of Global Top OTC Pet Medication Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global OTC Pet Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fleas & Ticks Removal
Table 6. Key Players of Pain Relief & Arthritis
Table 7. Key Players of Dewormers
Table 8. Key Players of Others
Table 9. Global OTC Pet Medication Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global OTC Pet Medication Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global OTC Pet Medication Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global OTC Pet Medication Market Share by Regions (2015-2020)
Table 13. Global OTC Pet Medication Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global OTC Pet Medication Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. OTC Pet Medication Market Growth Strategy
Table 19. Main Points Interviewed from Key OTC Pet Medication Players
Table 20. Global OTC Pet Medication Revenue by Players (2015-2020) (Million US$)
Table 21. Global OTC Pet Medication Market Share by Players (2015-2020)
Table 22. Global Top OTC Pet Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Pet Medication as of 2019)
Table 23. Global OTC Pet Medication by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players OTC Pet Medication Product Solution and Service
Table 26. Date of Enter into OTC Pet Medication Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 29. Global OTC Pet Medication Market Size Share by Type (2015-2020)
Table 30. Global OTC Pet Medication Revenue Market Share by Type (2021-2026)
Table 31. Global OTC Pet Medication Market Size Share by Application (2015-2020)
Table 32. Global OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 33. Global OTC Pet Medication Market Size Share by Application (2021-2026)
Table 34. North America Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 35. North America Key Players OTC Pet Medication Market Share (2019-2020)
Table 36. North America OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 37. North America OTC Pet Medication Market Share by Type (2015-2020)
Table 38. North America OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 39. North America OTC Pet Medication Market Share by Application (2015-2020)
Table 40. Europe Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players OTC Pet Medication Market Share (2019-2020)
Table 42. Europe OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 43. Europe OTC Pet Medication Market Share by Type (2015-2020)
Table 44. Europe OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 45. Europe OTC Pet Medication Market Share by Application (2015-2020)
Table 46. China Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 47. China Key Players OTC Pet Medication Market Share (2019-2020)
Table 48. China OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 49. China OTC Pet Medication Market Share by Type (2015-2020)
Table 50. China OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 51. China OTC Pet Medication Market Share by Application (2015-2020)
Table 52. Japan Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players OTC Pet Medication Market Share (2019-2020)
Table 54. Japan OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 55. Japan OTC Pet Medication Market Share by Type (2015-2020)
Table 56. Japan OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 57. Japan OTC Pet Medication Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players OTC Pet Medication Market Share (2019-2020)
Table 60. Southeast Asia OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia OTC Pet Medication Market Share by Type (2015-2020)
Table 62. Southeast Asia OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia OTC Pet Medication Market Share by Application (2015-2020)
Table 64. India Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 65. India Key Players OTC Pet Medication Market Share (2019-2020)
Table 66. India OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 67. India OTC Pet Medication Market Share by Type (2015-2020)
Table 68. India OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 69. India OTC Pet Medication Market Share by Application (2015-2020)
Table 70. Central & South America Key Players OTC Pet Medication Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players OTC Pet Medication Market Share (2019-2020)
Table 72. Central & South America OTC Pet Medication Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America OTC Pet Medication Market Share by Type (2015-2020)
Table 74. Central & South America OTC Pet Medication Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America OTC Pet Medication Market Share by Application (2015-2020)
Table 76. Bayer Companion Animal Company Details
Table 77. Bayer Companion Animal Business Overview
Table 78. Bayer Companion Animal Product
Table 79. Bayer Companion Animal Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 80. Bayer Companion Animal Recent Development
Table 81. Boehringer Ingelheim Animal Health Company Details
Table 82. Boehringer Ingelheim Animal Health Business Overview
Table 83. Boehringer Ingelheim Animal Health Product
Table 84. Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 85. Boehringer Ingelheim Animal Health Recent Development
Table 86. Ceva Sante Animale Company Details
Table 87. Ceva Sante Animale Business Overview
Table 88. Ceva Sante Animale Product
Table 89. Ceva Sante Animale Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 90. Ceva Sante Animale Recent Development
Table 91. Merck Inc. Company Details
Table 92. Merck Inc. Business Overview
Table 93. Merck Inc. Product
Table 94. Merck Inc. Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 95. Merck Inc. Recent Development
Table 96. Zoetis Inc. Company Details
Table 97. Zoetis Inc. Business Overview
Table 98. Zoetis Inc. Product
Table 99. Zoetis Inc. Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 100. Zoetis Inc. Recent Development
Table 101. Elanco Company Details
Table 102. Elanco Business Overview
Table 103. Elanco Product
Table 104. Elanco Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 105. Elanco Recent Development
Table 106. Virbac SA Company Details
Table 107. Virbac SA Business Overview
Table 108. Virbac SA Product
Table 109. Virbac SA Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 110. Virbac SA Recent Development
Table 111. Vetoquinol SA Business Overview
Table 112. Vetoquinol SA Product
Table 113. Vetoquinol SA Company Details
Table 114. Vetoquinol SA Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 115. Vetoquinol SA Recent Development
Table 116. Frontline Company Details
Table 117. Frontline Business Overview
Table 118. Frontline Product
Table 119. Frontline Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 120. Frontline Recent Development
Table 121. Zymox Company Details
Table 122. Zymox Business Overview
Table 123. Zymox Product
Table 124. Zymox Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 125. Zymox Recent Development
Table 126. ChloraSeb Company Details
Table 127. ChloraSeb Business Overview
Table 128. ChloraSeb Product
Table 129. ChloraSeb Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 130. ChloraSeb Recent Development
Table 131. Sulfox Company Details
Table 132. Sulfox Business Overview
Table 133. Sulfox Product
Table 134. Sulfox Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 135. Sulfox Recent Development
Table 136. Adequan Company Details
Table 137. Adequan Business Overview
Table 138. Adequan Product
Table 139. Adequan Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 140. Adequan Recent Development
Table 141. Dechra Pharmaceuticals PLC Company Details
Table 142. Dechra Pharmaceuticals PLC Business Overview
Table 143. Dechra Pharmaceuticals PLC Product
Table 144. Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 145. Dechra Pharmaceuticals PLC Recent Development
Table 146. Nutramax Laboratories, Inc. Company Details
Table 147. Nutramax Laboratories, Inc. Business Overview
Table 148. Nutramax Laboratories, Inc. Product
Table 149. Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2015-2020) (Million US$)
Table 150. Nutramax Laboratories, Inc. Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global OTC Pet Medication Market Share by Type: 2020 VS 2026
Figure 2. Fleas & Ticks Removal Features
Figure 3. Pain Relief & Arthritis Features
Figure 4. Dewormers Features
Figure 5. Others Features
Figure 6. Global OTC Pet Medication Market Share by Application: 2020 VS 2026
Figure 7. Dogs & Cats Case Studies
Figure 8. Birds Case Studies
Figure 9. Fish & Reptiles Case Studies
Figure 10. Others Case Studies
Figure 11. OTC Pet Medication Report Years Considered
Figure 12. Global OTC Pet Medication Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global OTC Pet Medication Market Share by Regions: 2020 VS 2026
Figure 14. Global OTC Pet Medication Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global OTC Pet Medication Market Share by Players in 2019
Figure 17. Global Top OTC Pet Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Pet Medication as of 2019
Figure 18. The Top 10 and 5 Players Market Share by OTC Pet Medication Revenue in 2019
Figure 19. North America OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
Figure 1. Global OTC Pet Medication Market Share by Type: 2020 VS 2026
Figure 2. Fleas & Ticks Removal Features
Figure 3. Pain Relief & Arthritis Features
Figure 4. Dewormers Features
Figure 5. Others Features
Figure 6. Global OTC Pet Medication Market Share by Application: 2020 VS 2026
Figure 7. Dogs & Cats Case Studies
Figure 8. Birds Case Studies
Figure 9. Fish & Reptiles Case Studies
Figure 10. Others Case Studies
Figure 11. OTC Pet Medication Report Years Considered
Figure 12. Global OTC Pet Medication Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global OTC Pet Medication Market Share by Regions: 2020 VS 2026
Figure 14. Global OTC Pet Medication Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global OTC Pet Medication Market Share by Players in 2019
Figure 17. Global Top OTC Pet Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Pet Medication as of 2019
Figure 18. The Top 10 and 5 Players Market Share by OTC Pet Medication Revenue in 2019
Figure 19. North America OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America OTC Pet Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed